Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome

Diabetes, Obesity and Metabolism

Volumn 8, Issue 1, 2006, Pages 94-104

  Ko, G T C ^a   So, W Y ^b   Chan, Norman N ^b   Chan, W B ^b   Tong, P C Y ^b   Li, J ^b   Yeung, V ^b   Chow, C C ^b   Ozaki, R ^b   Ma, R C W ^b   Cockram, C S ^b   Chan, J C N ^b  

^a AH Nethersole Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular mortality; Chinese; Metabolic syndrome; Prognosis; Type2 diabetes

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC OBESITY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SMOKING; WORLD HEALTH ORGANIZATION;

EID: 33645994502     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00475.x     Document Type: Article

References (38)

1. Casiglia E, Zanette G, Mazza A et al. Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol 2000; 16: 677-684.
2. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172.
3. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 1979; 59: 8-13.
4. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741.
5. Bruno G, Merletti F, Boffetta P et al. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: An Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 297-301.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1994; 24: 465-468.
8. Erkelens DW. Insulin resistance syndrome and type 2 diabetes mellitus. Am J Cardiol 2001; 88: 38J-42J.
9. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001; 250: 105-120.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15: 539-553.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
12. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
13. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
14. Bognetti E, Meschi F, Balzano E et al. EURODIAB project 1989 registry for type 1 diabetes mellitus in Lombardy. Ann Ig 1992; 4: 165-171.
15. Friedewald WT, Levy RL, Fredrickason DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. World Health Organization Western Pacific Region, International Association for the Study of Obesity and the International Obesity Task Force. The Asia-Pacific perspective: Redefining obesity and its treatment. Australia: Health Communications Australia Pty Limited, 2000.
17. Diabetes Division, Hong Kong Society for Endocrinology, Metabolism, and Reproduction. A statement for health care professionals on type 2 diabetes mellitus in Hong Kong. Hong Kong Med J 2000; 6: 105-107.
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
19. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
20. Bonora E, Formentini G, Calcaterra F et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 2002; 25: 1135-1141.
21. Bonora E, Kiechl S, Willeit J et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 2003; 26: 1251-1257.
22. Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002; 19: 470-475.
23. Hanley AJG, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease. The San Antonio Heart Study. Diabetes Care 2002; 25: 1177-1184.
24. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: A population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998; 148: 958-966.
25. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100.
26. Yuyun MF, Khaw KT, Luben R et al. European prospective investigation into cancer in Norfolk (EPIC-Norfolk) population study. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population. Int J Epidemiol 2004; 33: 189-198.
27. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in type 2 diabetes: An independent predictor of cardiovascular mortality. Aust N Z J Med 1996; 26: 519-525.
28. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35.
29. Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-828.
30. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-521.
31. Taskinen MR. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41: 12-17.
32. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26: 1046-1053.
33. Kim KS, Owen WL, Williams D, Adams-Campbell LL. Comparison between BMI and conicity index on predicting coronary heart disease: The Framingham Heart Study. Ann Epidemiol 2000; 10: 424-441.
34. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol 1999; 149: 491-503.
35. Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 1999; 20: 269-277.
36. Gruberg L, Waksman R, Ajani AE et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002; 39: 1930-1936.
37. Balkau B, Eschwege E, Papoz L et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 1993; 307: 295-299.
38. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1997; 157: 650-656.